Towards the 13-valent pneumococcal conjugate universal vaccination: effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013

Towards the 13-valent pneumococcal conjugate universal vaccination: effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013

Item
http://www.wikidata.org/entity/Q34271575
Impact of pneumococcal conjugate vaccination: a retrospective study of hospitalization for pneumonia in North-East ItalyA reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009-2016)Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis.A population-based study on the impact of hospitalization for pneumonia in different age groups.Identifying an appropriate PCV for use in Senegal, recent insights concerning Streptococcus pneumoniae NP carriage and IPD in Dakar.Impact of ten-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in Finnish children--a population-based study.Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings.Reply to Farkouh RA et al. Comment on "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children"Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012A retrospective analysis of hospital discharge records for S. pneumoniae diseases in the elderly population of Florence, Italy, 2010-2012Impact of Pneumococcal Conjugate Universal Routine Vaccination on Pneumococcal Disease in Italian Children.Nasopharyngeal Pneumococcal Carriage among Healthy Children in Cyprus Post Widespread Simultaneous Implementation of PCV10 and PCV13 Vaccines.How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter ProjectEstimated hospitalization rate for diseases attributable to Streptococcus pneumoniae in the Veneto region of north-east ItalyHospitalizations for pneumonia, invasive diseases and otitis in Tuscany (Italy), 2002-2014: Which was the impact of universal pneumococcal pediatric vaccination?Distribution of Streptococcus pneumoniae serotypes in the northeast macro-region of São Paulo state/Brazil after the introduction of conjugate vaccine.Hospitalization rates and outcome of invasive bacterial vaccine-preventable diseases in Tuscany: a historical cohort study of the 2000-2016 period
P2860

Towards the 13-valent pneumococcal conjugate universal vaccination: effectiveness in the transition era between PCV7 and PCV13 in Italy, 2010-2013

Item
http://www.wikidata.org/entity/Q34271575
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Towards the 13-valent pneumoco ...... and PCV13 in Italy, 2010-2013
@ast
Towards the 13-valent pneumoco ...... and PCV13 in Italy, 2010-2013
@en
Towards the 13-valent pneumoco ...... and PCV13 in Italy, 2010-2013
@nl
type
label
Towards the 13-valent pneumoco ...... and PCV13 in Italy, 2010-2013
@ast
Towards the 13-valent pneumoco ...... and PCV13 in Italy, 2010-2013
@en
Towards the 13-valent pneumoco ...... and PCV13 in Italy, 2010-2013
@nl
prefLabel
Towards the 13-valent pneumoco ...... and PCV13 in Italy, 2010-2013
@ast
Towards the 13-valent pneumoco ...... and PCV13 in Italy, 2010-2013
@en
Towards the 13-valent pneumoco ...... and PCV13 in Italy, 2010-2013
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Towards the 13-valent pneumoco ...... and PCV13 in Italy, 2010-2013
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932